Global and United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Insights, Forecast to 2027

Table of Contents

1 Study Coverage
1.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Introduction
1.2 Market by Type
1.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type
1.2.2 Glycerin
1.2.3 Propylene Glycol
1.2.4 Sorbitol
1.2.5 Mannitol
1.2.6 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application
1.3.2 Industrial Application
1.3.3 Non-industrial Application
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size, Estimates and Forecasts
2.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue 2016-2027
2.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2016-2027
2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historical Market Size by Region (2016-2021)
2.3.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Region (2022-2027)
2.4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Region (2022-2027)

3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Competitor Landscape by Players
3.1 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Sales
3.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturer (2016-2021)
3.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Revenue
3.2.1 Key Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2016-2021)
3.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue in 2020
3.2.6 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Manufacturers
3.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturing Base Distribution, Product Types
3.4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Type (2016-2021)
4.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2016-2021)
4.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2016-2021)
4.1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Type (2022-2027)
4.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type (2022-2027)
4.2.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Application (2016-2021)
5.1.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2016-2021)
5.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2016-2021)
5.1.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2016-2021)
5.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Forecast by Application (2022-2027)
5.2.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
6.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
6.1.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales YoY Growth 2016-2027
6.1.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue YoY Growth 2016-2027
6.1.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Share in Global Market 2016-2027
6.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Players (International and Local Players)
6.2.1 United States Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Players by Sales (2016-2021)
6.2.2 United States Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Players by Revenue (2016-2021)
6.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historic Market Review by Type (2016-2021)
6.3.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type (2016-2021)
6.3.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Type (2016-2021)
6.3.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Type (2016-2021)
6.4 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2022-2027)
6.4.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Type (2022-2027)
6.4.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Type (2022-2027)
6.5 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Historic Market Review by Application (2016-2021)
6.5.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application (2016-2021)
6.5.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Application (2016-2021)
6.5.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price by Application (2016-2021)
6.6 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2022-2027)
6.6.2 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2022-2027)
6.6.3 United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price Forecast by Application (2022-2027)

7 North America
7.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
7.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Country
7.2.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021)
7.2.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Region
8.2.1 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2016-2021)
8.2.2 Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
9.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Country
9.2.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021)
9.2.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
10.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Country
10.2.1 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021)
10.2.2 Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Facts & Figures by Country
11.2.1 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 ABITEC Corporation
12.1.1 ABITEC Corporation Corporation Information
12.1.2 ABITEC Corporation Description and Business Overview
12.1.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.1.5 ABITEC Corporation Recent Development
12.2 AkzoNobel
12.2.1 AkzoNobel Corporation Information
12.2.2 AkzoNobel Description and Business Overview
12.2.3 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.2.5 AkzoNobel Recent Development
12.3 Archer Daniels Midland (ADM)
12.3.1 Archer Daniels Midland (ADM) Corporation Information
12.3.2 Archer Daniels Midland (ADM) Description and Business Overview
12.3.3 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.3.5 Archer Daniels Midland (ADM) Recent Development
12.4 BASF
12.4.1 BASF Corporation Information
12.4.2 BASF Description and Business Overview
12.4.3 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.4.5 BASF Recent Development
12.5 DowDuPont
12.5.1 DowDuPont Corporation Information
12.5.2 DowDuPont Description and Business Overview
12.5.3 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.5.4 DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.5.5 DowDuPont Recent Development
12.6 Evonik
12.6.1 Evonik Corporation Information
12.6.2 Evonik Description and Business Overview
12.6.3 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.6.5 Evonik Recent Development
12.7 J.M. Huber Corporation
12.7.1 J.M. Huber Corporation Corporation Information
12.7.2 J.M. Huber Corporation Description and Business Overview
12.7.3 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.7.4 J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.7.5 J.M. Huber Corporation Recent Development
12.8 Cargill
12.8.1 Cargill Corporation Information
12.8.2 Cargill Description and Business Overview
12.8.3 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.8.5 Cargill Recent Development
12.9 Eastman Chemical Company
12.9.1 Eastman Chemical Company Corporation Information
12.9.2 Eastman Chemical Company Description and Business Overview
12.9.3 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.9.5 Eastman Chemical Company Recent Development
12.11 ABITEC Corporation
12.11.1 ABITEC Corporation Corporation Information
12.11.2 ABITEC Corporation Description and Business Overview
12.11.3 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales, Revenue and Gross Margin (2016-2021)
12.11.4 ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Products Offered
12.11.5 ABITEC Corporation Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Industry Trends
13.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
13.3 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
13.4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Glycerin
Table 3. Major Manufacturers of Propylene Glycol
Table 4. Major Manufacturers of Sorbitol
Table 5. Major Manufacturers of Mannitol
Table 6. Major Manufacturers of Others
Table 7. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Regions (2016-2021) & (K Units)
Table 10. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Regions (2016-2021)
Table 11. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers by Revenue (US$ Million) in 2020
Table 19. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Manufacturers (2016-2021)
Table 21. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Solid Dosage Forms (OSDF) and Pharma Excipients as of 2020)
Table 23. Key Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (2016-2021) (USD/Unit)
Table 24. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Type
Table 26. Date of International Manufacturers Enter into Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Type (2016-2021) (K Units)
Table 29. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2016-2021)
Table 30. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2016-2021)
Table 32. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Application (2016-2021) (K Units)
Table 39. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2016-2021)
Table 40. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2016-2021)
Table 42. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units) of Key Companies (2016-2021)
Table 49. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Company (2016-2021)
Table 50. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) by Company (2016-2021)
Table 51. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Company (2016-2021)
Table 52. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units) by Type (2016-2021)
Table 53. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2016-2021)
Table 54. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Type (2016-2021)
Table 56. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units) by Type (2022-2027)
Table 57. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Type (2022-2027)
Table 58. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Type (2022-2027)
Table 60. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Type (2022-2027)
Table 61. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units) by Application (2016-2021)
Table 62. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2016-2021)
Table 63. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Application (2016-2021)
Table 65. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units) by Application (2022-2027)
Table 66. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Share by Application (2022-2027)
Table 67. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Share by Application (2022-2027)
Table 69. United States Oral Solid Dosage Forms (OSDF) and Pharma Excipients Price (USD/Unit) by Application (2022-2027)
Table 70. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021) & (K Units)
Table 71. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2016-2021)
Table 72. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Region (2016-2021)
Table 78. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021) & (K Units)
Table 79. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2016-2021)
Table 80. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2016-2021)
Table 82. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Revenue Market Share by Country (2016-2021)
Table 90. ABITEC Corporation Corporation Information
Table 91. ABITEC Corporation Description and Business Overview
Table 92. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. ABITEC Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product
Table 94. ABITEC Corporation Recent Development
Table 95. AkzoNobel Corporation Information
Table 96. AkzoNobel Description and Business Overview
Table 97. AkzoNobel Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. AkzoNobel Product
Table 99. AkzoNobel Recent Development
Table 100. Archer Daniels Midland (ADM) Corporation Information
Table 101. Archer Daniels Midland (ADM) Description and Business Overview
Table 102. Archer Daniels Midland (ADM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Archer Daniels Midland (ADM) Product
Table 104. Archer Daniels Midland (ADM) Recent Development
Table 105. BASF Corporation Information
Table 106. BASF Description and Business Overview
Table 107. BASF Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. BASF Product
Table 109. BASF Recent Development
Table 110. DowDuPont Corporation Information
Table 111. DowDuPont Description and Business Overview
Table 112. DowDuPont Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. DowDuPont Product
Table 114. DowDuPont Recent Development
Table 115. Evonik Corporation Information
Table 116. Evonik Description and Business Overview
Table 117. Evonik Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Evonik Product
Table 119. Evonik Recent Development
Table 120. J.M. Huber Corporation Corporation Information
Table 121. J.M. Huber Corporation Description and Business Overview
Table 122. J.M. Huber Corporation Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. J.M. Huber Corporation Product
Table 124. J.M. Huber Corporation Recent Development
Table 125. Cargill Corporation Information
Table 126. Cargill Description and Business Overview
Table 127. Cargill Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Cargill Product
Table 129. Cargill Recent Development
Table 130. Eastman Chemical Company Corporation Information
Table 131. Eastman Chemical Company Description and Business Overview
Table 132. Eastman Chemical Company Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Eastman Chemical Company Product
Table 134. Eastman Chemical Company Recent Development
Table 135. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Trends
Table 136. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Drivers
Table 137. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Challenges
Table 138. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Restraints
Table 139. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Customers List
Table 140. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Picture
Figure 2. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Type in 2020 & 2027
Figure 3. Glycerin Product Picture
Figure 4. Propylene Glycol Product Picture
Figure 5. Sorbitol Product Picture
Figure 6. Mannitol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Application in 2020 & 2027
Figure 9. Industrial Application
Figure 10. Non-industrial Application
Figure 11. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Report Years Considered
Figure 12. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size 2016-2027 (US$ Million)
Figure 14. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales 2016-2027 (K Units)
Figure 15. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region (2016-2021)
Figure 17. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Sales Market Share by Region in 2020
Figure 18. Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Rev